Drug Shortage Report for ACT TERBINAFINE
| Report ID | 111874 |
| Drug Identification Number | 02254727 |
| Brand name | ACT TERBINAFINE |
| Common or Proper name | TERBINAFINE 250MG TABLET |
| Company Name | TEVA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | TERBINAFINE |
| Strength(s) | 250MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 30 |
| ATC code | D01BA |
| ATC description | ANTIFUNGALS FOR SYSTEMIC USE |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2020-04-08 |
| Estimated end date | |
| Actual end date | 2020-05-31 |
| Shortage status | Resolved |
| Updated date | 2023-10-03 |
| Company comments | Item is under review to be discontinued - Transitioned |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v21 | 2021-06-03 | English | Compare |
| v22 | 2021-06-03 | French | Compare |
| v23 | 2021-06-17 | English | Compare |
| v24 | 2021-06-17 | French | Compare |
| v25 | 2021-08-27 | English | Compare |
| v26 | 2021-08-27 | French | Compare |
| v27 | 2021-09-02 | English | Compare |
| v28 | 2021-09-02 | French | Compare |
| v29 | 2021-10-14 | English | Compare |
| v30 | 2021-10-14 | French | Compare |
| v31 | 2023-10-03 | English | Compare |